- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/00 - Drugs for immunological or allergic disorders
Patent holdings for IPC class A61P 37/00
Total number of patents in this class: 8380
10-year publication summary
|
338
|
330
|
354
|
490
|
634
|
654
|
602
|
725
|
624
|
173
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
290 |
| Bristol-myers Squibb Company | 5080 |
147 |
| Novartis AG | 11238 |
125 |
| F. Hoffmann-La Roche AG | 7958 |
119 |
| Genentech, Inc. | 3742 |
75 |
| Incyte Corporation | 918 |
69 |
| Boehringer Ingelheim International GmbH | 4629 |
61 |
| Merck Patent GmbH | 5909 |
52 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
50 |
| Takeda Pharmaceutical Company Limited | 2961 |
48 |
| Glaxo Group Limited | 4496 |
46 |
| Hoffmann-La Roche Inc. | 3060 |
45 |
| Glaxosmithkline Intellectual Property Development Limited | 723 |
42 |
| Janssen Pharmaceutica N.V. | 3839 |
40 |
| AstraZeneca AB | 3042 |
39 |
| Jiangsu Hengrui Medicine Co., Ltd. | 780 |
38 |
| Rigel Pharmaceuticals, Inc. | 613 |
37 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 588 |
37 |
| Bayer Pharma AG | 1096 |
34 |
| Vertex Pharmaceuticals Incorporated | 1581 |
34 |
| Other owners | 6952 |